Judge: Teresa A. Beaudet, Case: 19STCV27357, Date: 2022-08-23 Tentative Ruling
Case Number: 19STCV27357 Hearing Date: August 23, 2022 Dept: 50
|
consumer advocacy group, inc., Plaintiff, vs. GAJU MARKET CORPORATION DBA CALIFORNIA MARKET, et al. Defendants. |
Case No.: |
19STCV27357 |
|
Hearing Date: |
August 23, 2022 |
|
|
Hearing Time: |
10:00 a.m. |
|
|
[TENTATIVE]
ORDER RE: MOTION TO APPROVE AND ENTER
CONSENT JUDGMENT BETWEEN PLAINTIFF CONSUMER ADVOCACY GROUP, INC., AND
DEFENDANT GAJU MARKET CORPORATION DBA CALIFORNIA MARKET |
||
Background
This is an action brought
under California’s Proposition 65 (California’s Safe Drinking Water and Toxic
Enforcement Act of 1986). Enacted by the voters in 1986, Proposition 65 (Health & Saf. Code, § 25249.5 et seq.) was designed to prevent the
contamination of drinking water with, and generally protect the public from
unknowing exposure to, harmful chemicals. Section
25249.5 provides in part: “No person in the course of doing business shall
knowingly discharge or release a chemical known to the state to cause cancer or
reproductive toxicity into water or onto or into land where such chemical
passes or probably will pass into a source of drinking water.” (Health &
Saf. Code, § 25249.5.)
Plaintiff Consumer Advocacy Group, Inc.
(“Plaintiff”) filed this action against Defendant Gaju Market Corporation dba
California Market (“Defendant”) on August 5, 2019. Plaintiff alleges that
Defendant violated Proposition 65 by manufacturing, distributing, and/or
selling tongs with plastic handles that contain the chemical Bis(2-ethylhexyl)
phthalate (“DEHP”), without first providing any type of clear and reasonable
warning of such to the exposed persons before the time of exposure. (Compl., ¶¶ 16, 25-26, 29.) Plaintiff alleges
that DEHP is known to cause developmental, female, and male reproductive
toxicity. (Compl., ¶ 17.)
Plaintiff and Defendant
have entered into a Proposed Consent Judgment. Plaintiff now moves for court
approval of the Proposed Consent Judgment. The motion is unopposed. On August
3, 2022, the Court issued an Order continuing the hearing on the instant motion
to August 23, 2022. The Court ordered Plaintiff to file with the Court and serve by August 16, 2022 a declaration that
satisfies the requirements of California
Code of Regulations, title 11, section 3204, subdivision (b)(6)(B). On August 16, 2022, Plaintiff filed a
supplemental declaration of Michael Marcus in support of the instant
motion.
Discussion
Health
and Safety Code section 25249.7(f)(4) requires court approval of all Proposition 65 settlements (other than
voluntary dismissals) of actions brought by a person in the public interest.
The court can approve the settlement only if it finds that:
(A) Any warning required by the settlement complies with this chapter.
(B) Any award of attorneys’ fees is reasonable under California law.
(C) Any penalty amount is reasonable based on the criteria set forth in
paragraph (2) of subdivision (b).
The plaintiff has the
burden of producing sufficient evidence to sustain each required finding. (Health & Saf. Code, § 25249.7(f).)
The Warning’s Compliance
Health
and Safety Code section 25249.6
provides, “No person in the course of doing business shall knowingly and
intentionally expose any individual to a chemical known to the state to cause
cancer or reproductive toxicity without first giving clear and reasonable
warning to such individual, except as provided in Section
25249.10.” Pursuant to California Code of Regulations, title 27,
section 25601, subdivision (a), “[a] warning is ‘clear
and reasonable’ within the meaning of Section 25249.6 of the Act if the warning
complies with all applicable requirements of this article.”
“Unless otherwise specified
in Section 25607 et seq, a consumer product exposure warning meets the
requirements of this subarticle if it complies with the content requirements in
Section 25603 and is provided using one or more of the following methods:…(3) A warning on the label
that complies with the content requirements in Section 25603(a)…” (27 Cal. Code
Regs., § 25602(a)(3).) California Code of
Regulations, title 27, section 25603, subdivision (a), provides in pertinent
part, “[u]nless otherwise specified in Section
25607.1 et seq., a warning meets the requirements of this subarticle if it is
provided using one or more of the methods required in Section 25602 and
includes all the following elements:
(1) A symbol consisting of a black
exclamation point in a yellow equilateral triangle with a bold black outline.
Where the sign, label or shelf tag for the product is not printed using the
color yellow, the symbol may be printed in black and white. The symbol shall be
placed to the left of the text of the warning, in a size no smaller than the
height of the word “WARNING”.
(2) The word “WARNING:” in
all capital letters and bold print, and:…
(D) For exposures to a chemical that is listed as both a
carcinogen and a reproductive toxicant, the words, “This product can expose you
to chemicals including [name of one or more chemicals], which is [are] known to
the State of California to cause cancer and birth defects or other reproductive
harm. For more information go to www.P65Warnings.ca.gov.”
In addition, “[c]onsumer
product exposure warnings must be prominently displayed on a label, labeling,
or sign, and must be displayed with such conspicuousness as compared with other
words, statements, designs or devices on the label, labeling, or sign, as to
render the warning likely to be seen, read, and understood by an ordinary
individual under customary conditions of purchase or use.” (27 Cal. Code Regs, § 25601(c).)
Moreover,
“[r]eformulation of a product, . . . or other changes in the defendant’s
practices that reduce or eliminate the exposure to a listed chemical, in lieu
of the provision of a warning, are presumed to confer a significant benefit on
the public.” (11 Cal. Code Regs., § 3201(b)(2).)
Here, Section 3.1 of the
Proposed Consent Judgment provides, “After the Effective Date, Defendant shall
not sell, offer for sale, or order for sale any Covered Products unless the level
of DEHP in the Covered Products does not exceed more than 0.1% (1,000 parts per
million) by weight.” (Yeroushalmi Decl., ¶ 4, Ex. A.) “Effective Date” means the date that the Proposed Consent Judgment
is approved by the Court. (Proposed Consent Judgment, § 2.2.)
“Covered
Products” are identified as “Tongs
with Plastic Handles, which includes but is not limited to: ‘LXD;’ ‘MADEIN
CHINA;’ ‘14;’ HQ S/S TONG (J0189);’ ‘893483703304’ sold by or supplied by
Defendant.” (Proposed Consent Judgment,
§ 2.1.) Plaintiff asserts
that CAG’s test results on the Covered Product revealed DEHP levels as high as
46.9 percent, such that the reformulation level significantly reduces the
presence of these chemicals compared to CAG’s test results. (Yeroushalmi Decl.,
¶ 7, Ex. D.)
Section 3.2 of the Proposed Consent Judgment provides,
“For any Covered Products whose DEHP content exceeds .1 % still existing in
Defendant inventory as of the Effective Date, Defendant shall place a clear and
reasonable warning Proposition 65 compliant warning on them, consistent with 27
CCR section 25600 et seq. In
consideration of the fact that Defendants have agreed to only order for manufacture
reformulated Covered products, parties agree to the following language for Covered
Products in existing inventory that contain more than 0.1% DEHP by weight:
WARNING:
This product can expose you to chemicals including Bis(2-ethylhexyl)
phthalate
(DEHP) which is known to the State of California to cause Cancer, birth defects
or other reproductive harm. For more information go to www.P65Wamings.ca.gov.”[1]
Section
3.3 provides, “Any warning
provided pursuant to this section shall be affixed
to the packaging or hangtag of, or directly
on, the Covered Products, and be prominently placed with such conspicuousness as compared with other words,
statements, designs, or devices as to render it likely
to be read and understood by an ordinary individual under customary conditions before
purchase or use. The equilateral triangle pictogram shall be in yellow with a black
exclamation mark; provided however, the pictogram may be in white instead of
yellow if the Covered Product label does not contain the color yellow.”
The Court finds that the
injunctive relief required by the Proposed Consent Judgment complies with
Proposition 65.
Reasonableness of Award of Attorneys’ Fees and Costs
The Proposed Consent
Judgment requires Defendant to reimburse Plaintiff for attorneys’ fees and
costs incurred in prosecuting this action in the amount of $52,000.00.
(Proposed Consent Judgment, § 4.1.3.) This motion is accompanied by a
declaration from Plaintiff’s counsel justifying the amount of the fee award. Plaintiff’s
counsel sets forth the experience and skill of each of the attorneys who billed
on this case, as well as the requested hourly rate for each attorney. (Yeroushalmi
Decl., ¶¶ 11-16.) Plaintiff’s counsel also sets forth the experience and skill
of non-attorney support staff who billed on this case, as well as the requested
hourly rate for each support staff member. (Yeroushalmi Decl., ¶ 17.)
Plaintiff’s counsel attests to the fact that his firm has incurred
approximately $82,073.50 in attorney’s fees from the inception of this case
(beginning in August 2019) through the present. (Yeroushalmi Decl., ¶ 20.) No
time records are included, but Plaintiff’s counsel does provide a detailed
review of the work performed by the attorneys. (Yeroushalmi Decl., ¶ 27-31.)
The Court finds that the
amount allocated for attorney’s fees in the Proposed Consent Judgment is
reasonable.
Reasonableness of Penalty Amount
The Consent Judgment
provides that Defendant will pay civil penalties in the amount of $7,440.00. (Proposed
Consent Judgment, § 4.1.1.) In compliance with Health
and Safety Code section 25249.12, the Consent Judgment provides that 75% ($5,580.00) of the civil penalty shall be
disbursed to the California Office of Environmental Health Hazard Assessment (the
“OEHHA”), and the remaining 25% ($1,860.00) shall be paid to Plaintiff. (Ibid.)
An additional $5,560.00 will be paid to Plaintiff as an
additional settlement payment. (Proposed Consent Judgment, § 4.1.2.)
Any civil penalty
assessed under Health and Safety Code section
25249.7(b)(2) must take into consideration certain factors including the
following:
(A) The nature and extent of the violation;
(B) The number of, and severity of, the violations;
(C) The economic effect of the penalty on the violator;
(D) Whether the violator took good faith measures to comply with this
chapter and the time these measures were taken;
(E) The willfulness of the violator’s misconduct;
(F) The deterrent effect that the imposition of the penalty would have on
both the violator and the regulated community as a whole; and
(G) Any other factor that justice may require.
Significantly, the Proposition 65 regulations explicitly
state that “[a] settlement
with little or no penalty may be entirely appropriate or not, based on the
facts or circumstances of a particular case.” (11
Cal. Code Regs., § 3203(a).)
Plaintiff asserts that
Defendant’s violations are sufficiently significant and severe, as the subject
chemicals are highly toxic and the amount of the chemicals found represents a severe
violation. (Yeroushalmi Decl., ¶ 7, Ex. D.) Plaintiff asserts that Defendant’s
willingness to provide warnings if the DEHP levels exceed certain low
thresholds exhibits less willfulness for the alleged violations. (Yeroushalmi
Decl., ¶ 9.) Defendant has agreed to act immediately, upon approval of the Proposed
Consent Judgment. Lastly, Plaintiff asserts that the total payment to settle
this case ($65,000.00) should be a sufficient deterrent against future
violations. The Court finds that the civil penalty amount provided for in the Proposed
Consent Judgment is reasonable.
With respect to the
additional settlement payment, Plaintiff contends that it may be viewed as an
offset to the civil penalty under California Code
of Regulations, title 11, section 3203(d). Per section
3203, “[t]he plaintiff must demonstrate to the satisfaction of the court
that it is in the public interest to offset the civil penalty required by
statute.” (11 CCR § 3203(d).) Here, section 4.1.2 of the Proposed Consent Judgment
provides that 80% of the additional settlement payment will be used for “fees of
investigation, purchasing and testing for the Proposition 65 Listed Chemical in
various products, and for expert fees for evaluating exposures through various mediums…and
the cost of hiring consulting and retaining experts who assist with the
extensive scientific analysis necessary for those files in litigation and to
offset the costs of future litigation enforcing Proposition 65 but excluding
attorney fees.” 20% of the additional settlement payment will be used for “administrative
costs incurred during investigation and litigation to reduce the public’s
exposure to the Proposition 65 Listed Chemical by notifying those persons and/or
entities believed to be responsible for such exposures and attempting to
persuade those persons and/or entities to reformulate their products or the source
of exposure to completely eliminate or lower the level of the Proposition 65
Listed Chemical…” (Proposed Consent Judgment, § 4.1.2.)
The Court finds that the
additional settlement payment is in the public interest as it
does
not exceed the 75% of the civil penalty paid to the OEHHA (11 CCR § 3204(b)(1)); it will be used for activities that
have a nexus to the violations (11 CCR § 3204(b)(2));
Plaintiff is an accountable entity (11 CCR § 3204(b)(3));
the activities are sufficiently described (11 CCR § 3204(b)(4)); and the activities will be sufficiently
documented as Plaintiff will provide to the Attorney General copies of
documentation demonstrating how the funds have been spent within 30 days of a
request from the Attorney General. (11 CCR § 3204(b)(5)).
Plaintiff will track expenditures of the additional settlement payments to
ensure that the funds are used solely for those categories of expenditures
identified in the Proposed Consent Judgment. (Marcus Decl., ¶ 10.) Finally, the Court is satisfied that the additional settlement payment
is proper, as the identity of
Plaintiff as a business qualified in California has been disclosed, there
are no economic interests to be disclosed, and Plaintiff does not intend to make grants to other entities. (11 CCR § 3204(b)(6); see
Marcus Decl., ¶¶ 3, 7; Suppl. Marcus Decl., p. 2.) The Court finds
that the additional settlement payment provided for in the Consent Judgment is
reasonable.
Conclusion
Based on the foregoing, Plaintiff’s motion to approve the Proposition
65 settlement and enter consent judgment is granted. The Court will sign the proposed
order and Proposed Consent Judgment, and will change the hearing date
referenced on the proposed order to August 23, 2022.
Plaintiff is ordered to give notice of this ruling.
DATED:
Hon. Teresa A.
Beaudet
Judge, Los
Angeles Superior Court
[1]The warning appears to be accompanied
by a symbol consisting of a black exclamation point in a yellow triangle with a
black outline. (See Proposed Consent Judgment, § 3.2.)